Eknoyan G Lameire N Eckardt K et al.

KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.

Kidney Int. 3: 5-14Schaefer F Stanhope R Scheil H Schönberg D Preece MA Schärer K

Pulsatile gonadotropin secretion in pubertal children with chronic renal failure.

Acta Endocrinol (Copenh). 120: 14-19Zoccali C Tripepi G Cutrupi S Pizzini P Mallamaci F

Low triiodothyronine: a new facet of inflammation in end-stage renal disease.

J Am Soc Nephrol. 16: 2789-2795Emmanouel DS Lindheimer MD Katz AI

Pathogenesis of endocrine abnormalities in uremia.

Endocr Rev. 1: 28-44Astor BC Muntner P Levin A Eustace JA Coresh J

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).

Arch Intern Med. 162: 1401-1408

Anemia in renal disease: diagnosis and management.

Blood Rev. 24: 39-47

Erythropoietin.

N Engl J Med. 325: 1176-1177

Anemia in renal insufficiency.

Rev Clin Exp Hematol. : 12-20

Long-term impact of recombinant human erythropoietin on transfusion support in patients with chronic renal failure.

Immunohematology. 12: 1-3Locatelli F Aljama P Bárány P et al.

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

Nephrol Dial Transplant. : ii1-i47Golper TA Wolfson M Ahmad S et al.

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.

Kidney Int. 38: 904-911Kooistra MP Struyvenberg A van Es A

The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels.

Nephron. 57: 127-128Golper TA Goral S Becker BN Langman CB

L-carnitine treatment of anemia.

Am J Kidney Dis. 41: S27-S34Matsumura M Hatakeyama S Koni I Mabuchi H Muramoto H

Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.

Nephron. 72: 574-578Nikolaos S George A Telemachos T Maria S Yannis M Konstantinos M

Effect of L-carnitine supplementation on red blood cells deformability in hemodialysis patients.

Ren Fail. 22: 73-80Bérard E Barrillon D Iordache A Bayle J Cassuto-Viguier E

Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients.

Nephron. 68: 145Labonia WD Morelli Jr, OH Gimenez MI Freuler PV Morelli OH

Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients.

Kidney Int. 32: 754-759Stavroulopoulos A Cassidy MJ Porter CJ Hosking DJ Roe SD

Vitamin D status in renal transplant recipients.

Am J Transplant. 7: 2546-2552González EA Sachdeva A Oliver DA Martin KJ

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study.

Am J Nephrol. 24: 503-510Tomida K Hamano T Mikami S et al.

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

Bone. 44: 678-683

25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease.

J Bone Miner Res. 21: 1778-1784Milinković N Majkić-Singh NT Mirković DD Beletić AD Pejanović SD Vujanić ST

Relation between 25(OH)-vitamin D deficiency and markers of bone formation and resorption in haemodialysis patients.

Clin Lab. 55: 333-339

Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease.

Dis Markers. 2015868961Isakova T Wahl P Vargas GS et al.

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Kidney Int. 79: 1370-1378Nakano C Hamano T Fujii N et al.

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Clin J Am Soc Nephrol. 7: 810-819Lu CL Yeih DF Hou YC et al.

The emerging role of nutritional vitamin D in secondary hyperparathyroidism in CKD.

Nutrients. 10: 1890Bolasco PG Ghezzi PM Ferrara R et al.

Effect of on-line hemodiafiltration with endogenous reinfusion (HFR) on the calcium-phosphorus metabolism: medium-term effects.

Int J Artif Organs. 29: 1042-1052Fernández-Martín JL Carrero JJ Benedik M et al.

COSMOS: the dialysis scenario of CKD-MBD in Europe.

Nephrol Dial Transplant. 28: 1922-1935Alfieri C Regalia A Zanoni F Vettoretti S Cozzolino M Messa P

The importance of adherence in the treatment of secondary hyperparathyroidism.

Blood Purif. 47: 37-44Block GA Martin KJ de Francisco AL et al.

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

N Engl J Med. 350: 1516-1525

Secondary and tertiary hyperparathyroidism in chronic kidney disease: an endocrine and renal perspective.

Indian J Endocrinol Metab. 23: 391

Nutrition counseling in clinical practice: how clinicians can do better.

JAMA. 318: 1101-1102

Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake.

J Am Diet Assoc. 96: 1268-1270Kalantar-Zadeh K Gutekunst L Mehrotra R et al.

Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease.

Clin J Am Soc Nephrol. 5: 519-530Ramirez JA Emmett M White MG et al.

The absorption of dietary phosphorus and calcium in hemodialysis patients.

Kidney Int. 30: 753-759Schlemmer U Frølich W Prieto RM Grases F

Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis.

Mol Nutr Food Res. 53: S330-S375Gupta RK Gangoliya SS Singh NK

Reduction of phytic acid and enhancement of bioavailable micronutrients in food grains.

J Food Sci Technol. 52: 676-684

Demineralization of a wide variety of foods for the renal patient.

J Ren Nutr. 11: 90-96León JB Sullivan CM Sehgal AR

The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.

J Ren Nutr. 23 ()

Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?.

Semin Dial. 16: 186-188McCutcheon J Campbell K Ferguson M Day S Rossi M

Prevalence of phosphorus-based additives in the Australian food supply: a challenge for dietary education?.

J Ren Nutr. 25: 440-444

Dietary considerations to prevent loss of bone and renal function.

Nutrition. 16: 564-566

Phosphorus content of popular beverages (Am J Kidney Dis. 2015;65:969-71).

Am J Kidney Dis. 73: 435

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

Kidney Int Suppl. : S1-130

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Am J Kidney Dis. 42: S1-201DeFronzo RA Tobin JD Rowe JW Andres R

Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

J Clin Invest. 62: 425-435Fliser D Pacini G Engelleiter R et al.

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease.

Kidney Int. 53: 1343-1347Pham H Robinson-Cohen C Biggs ML et al.

Chronic kidney disease, insulin resistance, and incident diabetes in older adults.

Clin J Am Soc Nephrol. 7: 588-594

Insulin resistance as a therapeutic target for chronic kidney disease.

J Ren Nutr. 25: 226-229Liao MT Sung CC Hung KC Wu CC Lo L Lu KC

Insulin resistance in patients with chronic kidney disease.

J Biomed Biotechnol. 2012691369

Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease.

Semin Dial. 23: 378-382Mori TA Burke V Puddey I et al.

The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial.

J Hypertens. 27: 1863-1872Voytovich MH Simonsen C Jenssen T Hjelmesaeth J Asberg A Hartmann A

Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.

Nephrol Dial Transplant. 20: 413-418Chan DT Watts GF Irish AB Dogra GK

Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.

Nephrol Dial Transplant. 26: 3543-3549

1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.

Kidney Int. 53: 1353-1357Bulbul MC Dagel T Afsar B et al.

Disorders of lipid metabolism in chronic kidney disease.

Blood Purif. 46: 144-152

K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.

Am J Kidney Dis. 41 ()Ricardo AC Anderson CA Yang W et al.

Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Am J Kidney Dis. 65: 412-424Chiuve SE Rexrode KM Spiegelman D Logroscino G Manson JE Rimm EB

Primary prevention of stroke by healthy lifestyle.

Circulation. 118: 947

Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle.

Nutr Rev. 55: 383-389Parthasarathy S Khoo JC Miller E Barnett J Witztum JL Steinberg D

Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.

Proc Natl Acad Sci U S A. 87: 3894-3898Carluccio MA Siculella L Ancora MA et al.

Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals.

Arterioscler Thromb Vasc Biol. 23: 622-629Grundy SM Bilheimer D Chait A et al.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II).

JAMA. 269: 3015-3023Mekki K Bouzidi-Bekada N Kaddous A Bouchenak M

Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients.

Food Funct. 1: 110-115Morley JE Thomas DR Wilson MM

Cachexia: pathophysiology and clinical relevance.

Am J Clin Nutr. 83: 735-743Mak RH Ikizler AT Kovesdy CP Raj DS Stenvinkel P Kalantar-Zadeh K

Wasting in chronic kidney disease.

J Cachexia Sarcopenia Muscle. 2: 9-25

Ghrelin in chronic kidney disease.

Int J Pept. (): 2010Aguilera A Sánchez-Tomero JA Selgas R

Brain activation in uremic anorexia.

J Ren Nutr. 17: 57-61

National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure.

Am J Kidney Dis. 37: S66-S70Mehrotra R Berman N Alistwani A Kopple JD

Improvement of nutritional status after initiation of maintenance hemodialysis.

Am J Kidney Dis. 40: 133-142

Nutrition counseling impacts serum albumin levels.

J Ren Nutr. 14: 143-148

Interactions between thyroid disorders and kidney disease.

Indian J Endocrinol Metab. 16: 204-213Lim VS Fang VS Katz AI Refetoff S

Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.

J Clin Invest. 60: 522-534Lin CC Chen TW Ng YY Chou YH Yang WC

Thyroid dysfunction and nodular goiter in hemodialysis and peritoneal dialysis patients.

Perit Dial Int. 18: 516-521Guest PC Martins-de-Souza D Vanattou-Saifoudine N Harris LW Bahn S

Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.

Int Rev Neurobiol. 101: 145-168Eng PH Cardona GR Fang SL et al.

Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.

Endocrinology. 140: 3404-3410Pombo M Pombo CM Garcia A et al.

Hormonal control of growth hormone secretion.

Hormone Res. 55: 11-16

The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure.

J Am Soc Nephrol. 12: 1297-1306Haffner D Schaefer F Nissel R Wühl E Tönshoff B Mehls O

Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

N Engl J Med. 343: 923-930

Growth hormone axis in chronic kidney disease.

Pediatr Nephrol. 23: 41-48Furth SL Hwang W Yang C Neu AM Fivush BA Powe NR

Growth failure, risk of hospitalization and death for children with end-stage renal disease.

Pediatr Nephrol. 17: 450-455Postel-Vinay MC Tar A Crosnier H et al.

Plasma growth hormone-binding activity is low in uraemic children.

Pediatr Nephrol. 5: 545-547Tönshoff B Cronin MJ Reichert M et al.

Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

J Clin Endocrinol Metab. 82: 1007-1013Rabkin R Sun DF Chen Y Tan J Schaefer F

Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Pediatr Nephrol. 20: 313-318Fine RN Ho M Tejani A Blethen S

Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease.

J Pediatr. 142: 539-545Hokken-Koelega A Mulder P De Jong R Lilien M Donckerwolcke R Groothof J

Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.

Pediatr Nephrol. 14: 701-706

Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Pediatr Nephrol. 21: 917-930

Altered pulsatile secretion of luteinizing hormone in hypogonadal men with hyperprolactinaemia.

Clin Endocrinol. 21: 257-263

Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg?.

Arch Med Res. 44: 591-600Hou SH Grossman S Molitch ME

Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis.

Am J Kidney Dis. 6: 245-249Anantharaman P Schmidt RJ

Sexual function in chronic kidney disease.

Adv Chronic Kidney Dis. 14: 119-125Weisinger JR Bellorin-Font E

Outcomes associated with hypogonadism in women with chronic kidney disease.

Adv Chronic Kidney Dis. 11: 361-370Gipson D Katz LA Stehman-Breen C

Principles of dialysis: special issues in women.

in: Paper presented at: Seminars in Nephrology. Toorians A Janssen E Laan E et al.

Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response.

Nephrol Dial Transplant. 12: 2654-2663

USRDS 2002 annual data report.

National Institutes of Health, National Institute of Diabetes, Bethesda, MDLocatelli F Marcelli D Conte F et al.

Cardiovascular disease in chronic renal failure: the challenge continues.

Nephrol Dial Transplant. 15: 69-80

Clinical epidemiology of cardiovascular disease in chronic kidney disease.

Nephron Clin Pract. 101: c47-c52